Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

New research links two widely used diabetes drugs, semaglutide or tirzepatide, to a rare but potentially vision-threatening eye condition, raising questions about drug-specific risks and the need for ...

ZUG, Switzerland, April 01, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company"), a global biopharmaceutical company focused on innovations addressing ...

Ophthalmic diseases specialist Oculis Holding AG announced positive phase II data showing its serum-glucose corticoid kinase-2 activator OCS-05 protected nerve cells and improved vision in patients ...

Optic neuritis is an important cause of unilateral and acute visual loss in young adults, but other differential diagnoses should be considered, especially when the disease has an atypical ...

MIAMI--(BUSINESS WIRE)--Heru Inc., in collaboration with the Bascom Palmer Eye Institute, presented outstanding clinical data in four clinical studies at the ARVO meeting in Seattle, highlighting Heru ...

Please provide your email address to receive an email when new articles are posted on . A 57-year-old woman was transferred to Lahey Hospital and Medical Center emergency department from a community ...

Central retinal artery occlusion (CRAO) presents with acute and painless monocular vision loss; it is a form of acute ischemic stroke and a neuro-ophthalmic emergency. Diagnosing CRAO is largely ...